GILD vs NRIM · P/E 18, rev $7.80B vs P/E 13, rev $123.7M
Gilead Sciences Inc (GILD) versus Northrim BanCorp Inc (NRIM) — a side-by-side from cached financials, not a winner call.
Gilead Sciences Inc (GILD) is a drug manufacturers - general company listed on US. It is led by Daniel P. O'Day.
Northrim BanCorp Inc (NRIM) is a banks - regional company listed on US.
Latest reported GILD revenue for 2026-06-30 was $7.80B. Net income was -$10.50B. Revenue was up 12.1% from 2026-03-31 to 2026-06-30. GILD currently screens at market cap $160.15B and trailing P/E 17.5.
Latest reported NRIM revenue for 2026-06-30 was $123.7M. Net income was $29.0M. NRIM currently screens at market cap $522.9M and trailing P/E 12.6.
GILD currently screens at market cap $160.15B and trailing P/E 17.5. NRIM currently screens at market cap $522.9M and trailing P/E 12.6.
Not investment advice. Open the GILD and NRIM stock pages for the full models.
Not investment advice.